Lixoft Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 11

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $18.6M

Lixoft General Information


Developer of a modeling and simulation platform designed to reduce the cost and increase the success rate of new drug development. The company's platform deals in model-based drug development and advances to the modeling and simulation community in user-friendly tools designed to break the preclinical/ clinical/ vigilance divide for modeling and simulation, enabling drug developers to share information and synthesize them in studies.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Technology Systems
Discovery Tools (Healthcare)
Parent Company
Primary Office
  • 8 rue de la Renaissance
  • Batiment D
  • 92160 Antony
  • France
+33 09 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lixoft Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Apr-2020 $18.6M 000.00 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2010 Completed Startup
To view Lixoft’s complete valuation and funding history, request access »

Lixoft Comparisons

HQ Location
Total Raised
Post Valuation
Developer of a modeling and simulation platform designed to reduce the cost and increase the success rate of new drug de
Drug Discovery
Antony, France
11 As of 2020
00.00 0000-00-00


sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mi
00000 00000000000000
Barcelona, Spain
00 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lixoft Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
00000000 Corporation Barcelona, Spain 00 0000000000
You’re viewing 1 of 1 competitors. Get the full list »

Lixoft Patents

Lixoft Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4102511-A1 Method for determining an effect of a drug on a patient with a specific dose regimen Pending 11-Jun-2021 000000000 0

Lixoft Executive Team (3)

Name Title Board Seat Contact Info
Jonathan Chauvin Chief Executive Officer
Marc Lavielle Co-Founder, Board Member & Chief Scientist
Jérôme Kalifa Ph.D Co-Founder & Chairman
To view Lixoft’s complete executive team members history, request access »

Lixoft Board Members (2)

Name Representing Role Since
Jérôme Kalifa Ph.D Lixoft Co-Founder & Chairman 000 0000
Marc Lavielle Lixoft Co-Founder, Board Member & Chief Scientist 000 0000
To view Lixoft’s complete board members history, request access »

Lixoft Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lixoft Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
IncubAlliance Accelerator/Incubator Minority 000 0000 000000 0
To view Lixoft’s complete investors history, request access »